Education
About Us
Working with TipRanks
Follow Us
Tilray (TSE:TLRY)
TSX:TLRY
TLRY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.84 - C$4.00
Previous CloseN/A
Volume1.39M
Average Volume (3M)1.62M
Market Cap
$873.89M
Enterprise ValueC$1.26B
Total Cash (Recent Filing)C$189.70M
Total Debt (Recent Filing)C$373.79M
Price to Earnings (P/E)―
Beta1.89
Next Earnings
Apr 15, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding937,655,200
10 Day Avg. Volume1,661,112
30 Day Avg. Volume1,623,696
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.73
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.41Price Target Upside145.43% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Bulls Say, Bears Say
Bulls Say
Beverage ImprovementBeverage Improvement Plans are back on track with internalized production and focus on core markets, resulting in significant cost savings.
Facility InvestmentsThe company recently completed capital investments in a facility that allows better use of byproducts for vapes and infused pre-rolls, expected to improve Canadian adult-use trends.
Bears Say
Canadian Sales Decline2Q sales were below consensus estimates due to weaker Canadian adult-use cannabis sales.
EBITDA MarginsInvestments are impacting EBITDA margins negatively.
Price CompetitionCanadian adult-use will be challenging due to price competition.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.61% Insiders
0.41%
Mutual Funds
2.35% Other Institutional Investors
93.16% Public Companies and
Individual Investors
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was C$0.83 and its highest was C$4.00 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $873.89M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Apr 15, 2025 which is in 21 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Jan 10, 2025. The company reported -C$0.143 earnings per share for the quarter, missing the consensus estimate of -C$0.049 by -C$0.094.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.06.
How many shares outstanding does Tilray have?
Tilray has 937,655,200 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -C$0.143 in its last earnings report, missing expectations of -C$0.049. Following the earnings report the stock price went down -12.06%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TSE:TLRY
---
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$2.41 (145.43% Upside)
C$2.41 (145.43% Upside)
Blogger Sentiment
Bullish
TSE:TLRY Sentiment 82%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $35.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 6.6%
Last 30 Days ▼ 6.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.66%
12-Months-Change
Fundamentals
Return on Equity
-7.28%
Trailing 12-Months
Asset Growth
-3.21%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
---
TLRY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful expansion in the beverage and international cannabis segments. However, these positives were tempered by significant net loss and challenges in the Canadian cannabis market, as well as impacts from SKU rationalization. Though there are promising growth areas, the financial setbacks and market challenges balance the overall sentiment.Read More>---
TLRY Stock 12 Month Forecast
Average Price Target
C$2.41
▲(145.43% Upside)
Technical Analysis
Best Analysts Covering TLRY
1 Year
1 Year Success Rate
2/15 ratings generated profit
1 Year Average Return
-45.12%
reiterated a buy rating 2 months ago
Copying Owen Bennett's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -45.12% per trade.
---